People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other Technology, Biotechnology, Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Clearsense, LLC | — | Other Technology | Series C | $126.0M | $48.6M | 2024 |
| Alcresta Therapeutics, Inc. | — | Biotechnology | Series C | $75.9M | $409.6M | 2020 |
| BioIQ, Inc. | — | Other | Series B | $59.6M | $232.6M | 2019 |
| Sirion Holdings, Inc. | — | Pharmaceuticals | Series B | $30.2M | $941.4M | 2009 |
Todd Creech at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Todd Creech on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Barrett | 1 | 18 |
| Garheng Kong | 1 | 16 |
| James Topper | 1 | 12 |
| Charles Boorady | 1 | 8 |
| Stephen Kraus | 1 | 7 |
| Andrew Midler | 1 | 6 |
| Charles Cohen | 1 | 6 |
| Paul McCreadie | 1 | 6 |
| BARRY BUTLER | 1 | 6 |
| Andrew Schiff | 1 | 5 |
| Anthony Maida | 1 | 5 |
| Daniel Galles | 1 | 5 |
| Brandon Cady | 1 | 4 |
| Kevin Kinsella | 1 | 4 |
| ALBERT PRAST | 1 | 4 |
| Daniel Tasse | 1 | 4 |
| Anthony Williams | 1 | 4 |
| Brent Peus | 1 | 3 |
| Alexey Margolin | 1 | 3 |
| CURTIS - STRATMAN | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.